Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2003
10/30/2003CA2482907A1 Tissue specific genes and gene clusters
10/30/2003CA2482897A1 Two green fluorescent protein fragments and their use in a method for detecting protein - protein interactions
10/30/2003CA2482769A1 "doping" in walk-through mutagenesis
10/30/2003CA2482764A1 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them
10/30/2003CA2482719A1 Conjugates of membrane translocating agents and pharmaceutically active agents
10/30/2003CA2482597A1 Compositions and methods for regulation of plant gamma-tocopherol methyltransferase
10/30/2003CA2482477A1 Synthetic glyco-lipo-peptides as vaccines
10/30/2003CA2482464A1 Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease
10/30/2003CA2482368A1 Cytokine receptor
10/30/2003CA2481952A1 Immunological methods and compositions for the treatment of alzheimer's disease
10/30/2003CA2481724A1 Screening and therapeutic methods for treating circadian rhythm disorders
10/30/2003CA2481411A1 Phospholipases, nucleic acids encoding them and methods for making and using them
10/30/2003CA2481171A1 Hepatitis c virus assay systems
10/30/2003CA2480437A1 Methods of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof
10/30/2003CA2480404A1 Fc receptor homolog, reagents, and uses thereof
10/30/2003CA2427190A1 Production of recombinant epidermal growth factor in plants
10/29/2003EP1357189A2 Elicitor of the hypersensitive response in plants
10/29/2003EP1357188A1 Improvement of plant flower type targeting mads box gene
10/29/2003EP1357187A1 Novel physiologically active peptide and use thereof
10/29/2003EP1357186A1 Novel proteins and dnas thereof
10/29/2003EP1357183A1 Rice sucrose transporter gene promoter
10/29/2003EP1357181A1 Novel atopic dermatitis-associated gene and proteins
10/29/2003EP1357130A1 Basic fibroblastic growth factor with a specific collagen binding domain
10/29/2003EP1357129A2 Novel physiologically active peptide and use thereof
10/29/2003EP1357128A1 The preparation and usage of plasmodium fusion antigen
10/29/2003EP1357127A1 Hepatitis c virus epitopes specific for cd4+ t-cell lymphocytes
10/29/2003EP1356824A2 88KDA tumorigenic growth factor and antagonists
10/29/2003EP1356350A1 Silver-dispersing polypeptides
10/29/2003EP1356300A2 Oomycete ftsz-mt as a target for antimicrobial-specific biocides
10/29/2003EP1356293A2 Compositions and methods involving staphylococcus aureus protein staau-r9
10/29/2003EP1356285A2 Differentially expressed epitopes and uses thereof
10/29/2003EP1356284A2 Schizophrenia related genes
10/29/2003EP1356278A2 Methods and compositions for the identification and treatment of neurodegenerative disorders
10/29/2003EP1356102A2 Polymorphic sequences of the human abca1 gene, their uses, detection methods and kits
10/29/2003EP1356099A2 Method and nucleic acids for the analysis of astrocytomas
10/29/2003EP1356091A2 Method of detecting inflammatory lung disorders
10/29/2003EP1356080A1 Detection and identification of groups of bacteria
10/29/2003EP1356075A2 Protein scaffolds for antibody mimics and other binding proteins
10/29/2003EP1356069A2 Enhanced transfection system
10/29/2003EP1356068A2 Method for secretory production of glycoprotein having human-type sugar chain using plant cell
10/29/2003EP1356066A2 Control of gene expression in plants
10/29/2003EP1356064A2 Transcriptional regulator nucleic acids, polypeptides and methods of use thereof
10/29/2003EP1356061A2 Artificial transcriptional factors and methods of use
10/29/2003EP1356060A2 Twin-arginine translocation in bacillus
10/29/2003EP1356054A2 Bacillus thuringiensis proteins and vatiants thereof with pesticidal activity against coleopterans
10/29/2003EP1356053A2 Histone deacetylase inhibitors in diagnosis and treatment of thyroid neoplasms
10/29/2003EP1356051A2 Genes
10/29/2003EP1356050A2 Fluorescent proteins
10/29/2003EP1356049A2 Human sugar transporter proteins, potassium channel proteins, phospholipid transporter proteins and methods of use thereof
10/29/2003EP1356048A2 Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
10/29/2003EP1356047A2 Human proteins, polynucleotides encoding them and methods of using the same
10/29/2003EP1356046A2 Cytokine receptor zcytor19
10/29/2003EP1356045A2 Egf motif protein, egfl6 materials and methods
10/29/2003EP1356044A2 32146 and 57259, novel human transporters and uses thereof
10/29/2003EP1356043A2 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins
10/29/2003EP1356042A2 Carbohydrate-associated proteins
10/29/2003EP1356041A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/29/2003EP1356039A2 Down syndrome critical region 1-like 1 proteins
10/29/2003EP1356038A2 Compositions and methods relating to lung specific genes and proteins
10/29/2003EP1356036A2 Process and compositions for peptide, protein and peptidomimetic synthesis
10/29/2003EP1356034A2 Genes associated with allergic hypersensitivity and mast cell activation
10/29/2003EP1356030A1 Runx3 gene showing anti-tumor activity and use thereof
10/29/2003EP1356028A2 Protein modification and maintenance molecules
10/29/2003EP1356026A2 Micromonospora echinospora genes encoding for biosynthesis of calicheamicin and self-resistance thereto
10/29/2003EP1356025A1 Mammalian cancer cell and transgenic mammal carrying human protooncogene and kit for diagnosing cancer using said protooncogene
10/29/2003EP1356021A2 Method to remove citrate and aluminum from proteins
10/29/2003EP1355949A1 Conformationally abnormal forms of tau proteins and specific antibodies thereto
10/29/2003EP1355945A2 Flint glycoforms
10/29/2003EP1355944A2 Rtvp based compositions and methods for the treatment of prostate cancer
10/29/2003EP1355943A2 Neurotransmitter transporters
10/29/2003EP1355942A2 Glp-1 fusion proteins
10/29/2003EP1355941A2 Long lasting growth hormone releasing factor derivatives
10/29/2003EP1355940A2 Urotensin-ii agonists and antagonists
10/29/2003EP1355939A2 Interferons, uses and compositions related thereto
10/29/2003EP1355937A2 Mammalian alpha-helical protein-53
10/29/2003EP1355936A2 Polymer conjugates of neublastin and methods of using same
10/29/2003EP1355935A2 Secreted proteins
10/29/2003EP1355934A2 Compositions and methods relating to lung specific genes and proteins
10/29/2003EP1355933A2 Iron regulating protein-2 (irp-2) as a diagnostic for neurodegenerative diseases
10/29/2003EP1355932A2 Method and nucleic acids for the differentiation of astrocytoma, oligoastrocytoma and oligodendroglioma tumor cells
10/29/2003EP1355930A2 A method for identification, isolation and production of antigens to a specific pathogen
10/29/2003EP1355929A2 Basb209 polypeptides and polynucleotides from haemophilus influenzae
10/29/2003EP1355928A1 Universal carrier for targeting molecules to gb3 receptor expressing cells
10/29/2003EP1355927A2 Identification of the anti-sigma-28 factor in helicobacter pylori, in campylobacter jejuni and in pseudomonas aeruginosa and application thereof
10/29/2003EP1355926A2 Therapeutic compounds for ovarian cancer
10/29/2003EP1355925A2 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
10/29/2003EP1355924A2 Armed peptides
10/29/2003EP1355923A2 Immunomodulatory peptides derived from heat shock proteins and uses thereof
10/29/2003EP1355922A2 Stress proteins and peptides and methods of use thereof
10/29/2003EP1355921A2 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof
10/29/2003EP1355919A2 Molecules with extended half-lives, compositions and uses thereof
10/29/2003EP1355918A2 Recombinant protective protein from $i(streptococcus pneumoniae)
10/29/2003EP1355917A2 Compositions and methods relating to breast specific genes and proteins
10/29/2003EP1355668A1 Use of il-18 inhibitors for the treatment and/or prevention of heart disease
10/29/2003EP1355666A2 Use of rgm and its modulators
10/29/2003EP1355662A2 Method of preventing t cell-mediated responses by the use of the major histocompatibility complex class ii analog protein (map protein) from staphylococcus aureus
10/29/2003EP1355657A2 Gssp3 polynucleotides and polypeptides and uses thereof
10/29/2003EP1355656A2 Red blood cell as vehicle for agent-membrane translocation sequence conjugate
10/29/2003EP1355655A2 Compositions and methods for improving kidney function
10/29/2003EP1355529A2 Point mutant mice with hypersensitive alpha 4 nicotinic receptors: dopaminergic pathology and increased anxiety